esmolol has been researched along with phentolamine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Allen, MJ; Bennett, ED; Singer, M; Webb, AR | 1 |
| Marik, PE; Varon, J | 1 |
| Gabrielson, GV; Guffin, AV; Iberti, TJ; Kaplan, JA; Pertsemlidis, D | 1 |
| Guo, Z; Meng, XX; Xie, LS; Yang, JH | 1 |
| Cockcroft, JR; Coulson, JM | 1 |
2 review(s) available for esmolol and phentolamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The diagnosis and management of hypertensive crises.
Topics: Antihypertensive Agents; Aortic Aneurysm; Aortic Dissection; Clonidine; Diazoxide; Enalaprilat; Female; Fenoldopam; Humans; Hypertension; Labetalol; Nicardipine; Nifedipine; Nitroprusside; Phentolamine; Pre-Eclampsia; Pregnancy; Propanolamines; Trimethaphan | 2000 |
7 other study(ies) available for esmolol and phentolamine
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Effects of alterations in left ventricular filling, contractility, and systemic vascular resistance on the ascending aortic blood velocity waveform of normal subjects.
Topics: Adrenergic beta-Antagonists; Aorta; Blood Flow Velocity; Blood Pressure; Dobutamine; Echocardiography, Doppler; Humans; Methoxamine; Myocardial Contraction; Phentolamine; Propanolamines; Reference Values; Transducers; Vascular Resistance; Ventricular Function, Left | 1991 |
Continuous intravenous infusions of phentolamine and esmolol for preoperative and intraoperative adrenergic blockade in patients with pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenergic Antagonists; Aged, 80 and over; Anesthesia, General; Blood Pressure; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Infusions, Intravenous; Intraoperative Care; Male; Middle Aged; Phentolamine; Pheochromocytoma; Preoperative Care; Propanolamines | 1987 |
Acute myocardial ischemia up-regulates substance P in the retina of rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Disease Models, Animal; Male; Myocardial Ischemia; Phentolamine; Propanolamines; Protein Precursors; Rats; Rats, Sprague-Dawley; Retina; Substance P; Tachykinins; Time Factors; Up-Regulation | 2008 |
Sex differences in the systemic response to adrenoreceptor antagonists during sympathetic activation.
Topics: Adrenergic Agonists; Adult; Dose-Response Relationship, Drug; Female; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Male; Phentolamine; Propanolamines; Risk Factors; Sex Factors; Sympathetic Nervous System; Young Adult | 2011 |